Trial Search Results
Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes
The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.
Stanford is currently not accepting patients for this trial.
Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Device: CGM
- Other: Dietitian
- Overweight/obese (BMI 25-40 kg/m2)
- Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)
- On glucose-lowering medications (e.g., metformin)
- On weight-loss medications
Ages Eligible for Study
18 Years - 99 Years
Genders Eligible for Study